Teva shares slide after drug trial discontinuation
In short
Teva shares experienced a downturn following the discontinuation of a drug trial. Further details regarding the specific trial or the scale of the share decline were not immediately provided.
Key points
- Teva shares experienced a downturn following the discontinuation of a drug trial.: Teva shares experienced a downturn following the discontinuation of a drug trial.
- Further details regarding the specific trial or the scale of the share decline were not i…: Further details regarding the specific trial or the scale of the share decline were not immediately provided.